12:00 AM
Aug 05, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

RedHill preclinical data

In an animal model of collagen-induced arthritis (CIA), RedHill said RHB-104 significantly reduced disease severity. The company plans to start a Phase...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >